Cancer Research
Galectin-9 Emerges as New Target for Chronic Lymphocytic Leukemia Immunotherapy
Multi-omics study reveals exhausted T-cells in CLL lymph nodes and identifies galectin-9 as a promising therapeutic target for overcoming immune evasion.
Research Paper
Mar 27, 2026 13